Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus.
NCT ID: NCT05148429
Last Updated: 2021-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2020-01-01
2021-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to study the neonatal outcome of fetus confirm to have an abnormal positionning of mesenteric vessels
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fetuses with abnormal positionning of mesenteric vessels
All pregnant women with abnormal positionning of mesenteric vessels during second trimester scan
Ultrasound exam
Ultrasound exam
Fetal MRI
Fetal MRI
Postnatal abdominal ultrasound
Postnatal abdominal ultrasound
Pediatric Follow up
Pediatric Follow up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound exam
Ultrasound exam
Fetal MRI
Fetal MRI
Postnatal abdominal ultrasound
Postnatal abdominal ultrasound
Pediatric Follow up
Pediatric Follow up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Abnormal positionning of mesenteric vessels
* No other foetal malformation
* Singleton pregnancy
* Age \>18 years
Exclusion Criteria
* polymalformative syndrom
* Foetal malformation changing intestine disposition (gastroschisis, diaphragmatic hernia, heterotaxis…)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florent FUCHS, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL21_0684
Identifier Type: -
Identifier Source: org_study_id